U-CH1 Cells
US$ 500,00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Informações gerais
| Descrição | The U-CH1 cell line is the first established permanent human chordoma cell model, derived from a recurrent sacral chordoma. Chordomas are rare, slow-growing, locally invasive tumors that originate from notochordal remnants and primarily occur along the axial skeleton. U-CH1 exhibits cytogenetic features characteristic of chordoma, including clonal chromosomal aberrations such as der(1)t(1;22), deletions on chromosomes 4, 5, 6, 9, 10, and 20, and a derivative chromosome 20 resulting from t(10;20). Comparative genomic hybridization revealed recurrent DNA copy number changes in chordomas, particularly losses on 1p and 3p and gains on 7q, 5q, 12q, and 20. The cytogenetic profile of U-CH1 closely mirrors that of its parental tumor, reinforcing its biological relevance. Functionally and molecularly, U-CH1 and other chordoma cell lines display hallmark features of chordoma, including expression of brachyury, a transcription factor considered a key diagnostic marker. U-CH1 also harbors deletions of CDKN2A and lacks p16 protein expression, a recurrent genetic alteration in chordomas. This alteration leads to hyperactivation of the CDK4/6 pathway, rendering U-CH1 sensitive to CDK4/6 inhibitors such as palbociclib. Treatment with palbociclib significantly reduced phosphorylated Rb levels and inhibited proliferation in vitro, indicating that U-CH1 can be a valuable preclinical model for evaluating cell cycle-targeted therapies. The cell line has also been validated through mRNA and protein profiling, confirming its representativeness of primary chordoma tumors in expression and genomic patterns. |
|---|---|
| Organismo | Human |
| Tecido | Bone, sacrum |
| Doença | Sacral chordoma |
| Sinônimos | UCH-1, UCH1 |
Características
| Idade | 56 years |
|---|---|
| Gênero | Male |
| Etnia | White |
| Morfologia | Mesenchymal like, with variable vacuoles |
| Tipo de célula | Chordoma |
| Propriedades de crescimento | Adherent |
Dados regulatórios
| Referência | U-CH1 (Cytion catalog number 305885) |
|---|---|
| Nível de biossegurança | 1 |
| NCBI_TaxID | 9606 |
| Número de acesso do Cellosaurus | CVCL_4988 |
Dados biomoleculares
| Perfil mutacional | Mutation: TP53, Simple, p.Pro72Arg (c.215C>G), Unspecified |
|---|
Manuseio
| Meio de cultura | IMDM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 25 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 3.024 g/L NaHCO3 (Cytion article number 820800a) |
|---|---|
| Suplementos | Supplement the medium with 10% FBS |
| Reagente de dissociação | Accutase |
| Tempo de duplicação | ~1 week |
| Renovação de fluidos | 2 to 3 times per week |
| Meio de congelamento | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Descongelamento e cultura de células |
|
| Atmosfera de incubação | 37°C, 5% CO2, humidified atmosphere. |
| Condições de envio | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Condições de armazenamento | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Controle de Qualidade e Análise Molecular
| Esterilidade | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificado de Análise (CoA)
| Número do lote | Tipo de certificado | Data | Número de catálogo |
|---|---|---|---|
| 305885-020126 | Certificado de Análise | 03. Feb. 2026 | 305885 |